Lometraline
Lometraline is a pharmacological compound that was developed in the 1970s. It is classified as a naphthylaminopropane derivative and is structurally related to other psychoactive drugs such as MDA and MDMA.
History
Lometraline was first synthesized in the 1970s by a team of researchers at Upjohn, a pharmaceutical company that was later acquired by Pfizer. The compound was developed as part of a larger effort to create new antidepressant drugs. However, despite showing promise in early clinical trials, lometraline was never marketed.
Pharmacology
As a naphthylaminopropane derivative, lometraline is structurally similar to other psychoactive drugs such as MDA and MDMA. These compounds are known to affect the serotonin system in the brain, which is involved in regulating mood, appetite, and sleep, among other things.
Lometraline is believed to work by inhibiting the reuptake of serotonin, thereby increasing the amount of this neurotransmitter available in the brain. This is similar to the mechanism of action of many other antidepressant drugs. However, the exact pharmacological properties of lometraline are not well understood, as the compound was never fully developed or marketed.
Research and Clinical Trials
In the 1970s, lometraline was tested in clinical trials as a potential treatment for depression. Early results suggested that the compound had antidepressant effects and was well tolerated by patients. However, for reasons that are not entirely clear, lometraline was never marketed as an antidepressant.
Despite this, lometraline has been the subject of ongoing research interest. Some studies have suggested that the compound may have potential as a treatment for other conditions, such as post-traumatic stress disorder (PTSD) and anxiety disorders. However, these findings are preliminary and more research is needed to confirm them.
See Also
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
